Capital, LLC EcoR1, a director at $ZYME ($ZYME), bought 74,125 shares of the company on 01-13-2025. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 0.5%. Following this trade, they now own 15,485,203 shares of $ZYME stock.
$ZYME Insider Trading Activity
$ZYME insiders have traded $ZYME stock on the open market 16 times in the past 6 months. Of those trades, 11 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ZYME stock by insiders over the last 6 months:
- CAPITAL, LLC ECOR1 has made 11 purchases buying 886,451 shares for an estimated $12,456,920 and 0 sales.
- KENNETH GALBRAITH (Chair & CEO) has made 0 purchases and 2 sales selling 57,291 shares for an estimated $855,016.
- PAUL ANDREW MOORE (Chief Scientific Officer) has made 0 purchases and 2 sales selling 21,200 shares for an estimated $316,390.
- JEFFREY T L SMITH (EVP & Chief Medical Officer) sold 11,110 shares for an estimated $165,806
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ZYME Hedge Fund Activity
We have seen 66 institutional investors add shares of $ZYME stock to their portfolio, and 74 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BVF INC/IL removed 1,262,065 shares (-21.5%) from their portfolio in Q3 2024, for an estimated $15,838,915
- NEXTECH INVEST LTD. added 1,113,946 shares (+inf%) to their portfolio in Q3 2024, for an estimated $13,980,022
- MORGAN STANLEY added 867,422 shares (+20.5%) to their portfolio in Q3 2024, for an estimated $10,886,146
- DEUTSCHE BANK AG\ removed 829,266 shares (-35.2%) from their portfolio in Q3 2024, for an estimated $10,407,288
- CITADEL ADVISORS LLC removed 578,574 shares (-96.5%) from their portfolio in Q3 2024, for an estimated $7,261,103
- PERCEPTIVE ADVISORS LLC added 512,309 shares (+30.7%) to their portfolio in Q3 2024, for an estimated $6,429,477
- SILVERCREST ASSET MANAGEMENT GROUP LLC removed 511,173 shares (-64.2%) from their portfolio in Q3 2024, for an estimated $6,415,221
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
